Oncology Today with Dr Neil Love

Diffuse Large B-Cell Lymphoma — A Grand Rounds Program

November 4, 2026·1h 1m
Episode Description from the Publisher

Featuring a presentation by Dr Matthew Matasar, including the following topics:Selection of First-Line Therapy for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) (0:00)Clinician Survey Results Regarding First-Line Treatment of DLBCL (11:41)Current and Future Roles of Monoclonal and Bispecific Antibodies in Therapy for Relapsed/Refractory (R/R) DLBCL (16:01)Clinician Survey Results Regarding the Use of Monoclonal and Bispecific Antibodies for R/R DLBCL (28:47)Evidence-Based Incorporation of Antibody-Drug Conjugates (ADCs) into the Management of R/R DLBCL (34:34)Clinician Survey Results Regarding the Use of ADCs for R/R DLBCL (46:31)Discussion of Questions from the Community (50:20)CME information and select publications

Podzilla Summary coming soon

Sign up to get notified when the full AI-powered summary is ready.

Get Free Summaries →

Free forever for up to 3 podcasts. No credit card required.

Listen to This Episode

Get summaries like this every morning.

Free AI-powered recaps of Oncology Today with Dr Neil Love and your other favorite podcasts, delivered to your inbox.

Get Free Summaries →

Free forever for up to 3 podcasts. No credit card required.